Charles River Labs (CRL) Tops Q2 EPS by 10c; Boosts FY11 Guidance
Get Alerts CRL Hot Sheet
Price: $345.37 +1.68%
Revenue Growth %: -4.0%
Financial Fact:
Other, net: 1.02M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: -4.0%
Financial Fact:
Other, net: 1.02M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Charles River Laboratories International, Inc. (NYSE: CRL) reported Q2 EPS of $0.70, ex-items, $0.10 better than the analyst estimate of $0.60. Revenue for the quarter came in at $288.3 million versus the consensus estimate of $287.9 million.
Sees FY2011 EPS of $2.38-$2.48, versus prior guidance of $2.20-$2.40 and the consensus of $2.39.
Sees FY2011 EPS of $2.38-$2.48, versus prior guidance of $2.20-$2.40 and the consensus of $2.39.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Western Digital (WDC) Tops Q1 EPS by 56c, Offers Guidance
- Booz Allen Hamilton (BAH) Tops Q2 EPS by 28c, Misses on Revenue
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share